Akèy › Myelom Miltip › New Jersey › Clifton
Etid klinik pou Myelom Miltip nan Clifton, NJ
14 etid pou Myelom Miltip ap chèche patisipan nan sit nan ak bò kote Clifton (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Ap rekriteFaz 1/2
- Hackensack University Medical Center, Hackensack · 7 mi lwen
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Ap rekriteFaz 4
- Hackensack University Medical Center, Hackensack · 7 mi lwen
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma
Ap rekriteFaz 1
- Hackensack Meridian Health - John Theurer Cancer Center, Hackensack · 7 mi lwen
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
Ap rekriteFaz 2
- John Theurer Cancer Center, Hackensack · 7 mi lwen
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Ap rekriteFaz 3
- Hackensack Meridian Health, Hackensack · 7 mi lwen
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
Ap rekriteFaz 1/2
- Hackensack University Medical Center, Hackensack · 7 mi lwen
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Ap rekriteFaz 1
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack · 7 mi lwen
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 1/2
- Research Site, Hackensack · 7 mi lwen
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Ap rekriteFaz 1
- Hackensack University Medical Center, Hackensack · 7 mi lwen
Mosaic Trial for Stem Cell Transplant Recipients
Ap rekrite
- Hackensack Meridian Health, Nutley · 3 mi lwen
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Ap rekriteFaz 1
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi lwen
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Ap rekriteFaz 3
- GSK Investigational Site, Hackensack · 7 mi lwen
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Ap rekriteFaz 1
- Hackensack Meridian John Theurer Cancer Center, Hackensack · 7 mi lwen
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 1/2
- John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mi lwen
Etid Myelom Miltip nan lòt vil
- New York City, NY60 etid
- Boston, MA42 etid
- Atlanta, GA41 etid
- Houston, TX38 etid
- Durham, NC37 etid
- Nashville, TN32 etid
- Denver, CO27 etid
- Rochester, MN24 etid
- St. Louis, MO24 etid
- Columbus, OH24 etid
- Baldwin Park, CA23 etid
- Chicago, IL22 etid
Lòt etid nan Clifton
- Kansè Poumon ki pa ti selil24 etid
- Kansè (tout kalite)15 etid
- Kansè Metastatik12 etid
- Leksemi mieloïd egi12 etid
- Kansè pwostat12 etid
- Kansè nan tete12 etid
- Kansè ovè11 etid
- Kansè poumon10 etid
- Kansè Endomèt8 etid
- Kansè tete negatif triple8 etid
- Kansè kolorektal8 etid
- Karsinòm selil skuamèz tèt ak kou8 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.